Issue Date: November 24, 2008
DSM Will Divest Side-Chain Business
DSM has agreed to sell DSM Deretil, a maker of antibiotic side chains, to a management group. DSM says the transaction will allow its anti-infectives unit "to fully focus on its core future activity" in generic antibiotics. Deretil President Lluis Franquesa says his company will proceed with a previously announced plan to close part of its main plant in Villaricos, Spain, and move production to China. Deretil's sales are about $44 million per year.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society